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Abstract
Sendai virus C protein associates with the signal transducer and activator of transcription (STAT) 1 and inhibits the interferon (IFN)
response. We report a molecular basis for the anti-IFN- mechanism of Sendai virus. The C-terminal half-fragment of the C protein (D1)
retains both the STAT1-binding and the anti-IFN- abilities comparable to those of the full-size C. IFN- stimulation generates phosphory
lated-STAT1 even in the presence of the C or the D1. The phosphorylated-STAT1 generated in the D1-expressing cells forms an aberrant
complex, which does not bind to a -activated sequence (GAS) probe. Purified D1, indeed, inhibits in vitro the binding of the phosphory
lated-STAT1 dimer to the GAS probe. The D1, however, binds to the STAT1 N-terminal domain, but not the DNA binding domain. These
results suggest the possibility that the C protein prevents the -activated factor from binding to GAS elements through its interaction with
the STAT1 N-terminal domain.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Paramyxoviruses evolve their own strategies for antago-
nizing the host interferon (IFN) system (for reviews, see
Garcia-Sastre, 2001; Goodbourn et al., 2000; Gotoh et al.,
2001, 2002). For members of the Rubulavirus genus, virus-
encoded V proteins function as an IFN antagonist (Didcock
et al., 1999b; Kawano et al., 2001; Kubota et al., 2001;
Nishio et al., 2001; Parisien et al., 2001) and inhibit IFN
signaling by targeting the signal transducer and activator of
transcription (STAT) 1 or STAT2 for proteasome-mediated
degradation (Andrejeva et al., 2002; Didcock et al., 1999a,
1999b; Fujii et al., 1999; Kubota et al., 2001; Nishio et al.,
2001; Parisien et al., 2001; Young et al., 2000). Depending
on their target molecules, the STAT1-targeting viruses
(simian viruses 5 and 41, and mumps virus) inhibit both
IFN-/ and IFN- signaling, whereas the STAT2-target-
ing virus (human parainfluenza virus type 2) inhibits only
IFN-/ signaling. On the other hand, Sendai virus (SeV) of
the Respirovirus genus, uses a C protein instead of the V
protein for circumventing the IFN response (Garcin et al.,
1999; Gotoh et al., 1999). SeV C protein inhibits both
IFN-/ and IFN- signaling, but never causes degradation
of STATs like the Rubulavirus V protein in most cell types
(Garcin et al., 1999; Gotoh et al., 1999, 2003; Kato et al.,
2001; Komatsu et al., 2000; Takeuchi et al., 2001; Young et
al., 2000), except for some cells such as NIH3T3 mouse
embryo fibroblasts (Garcin et al., 2000, 2001, 2002, 2003).
The SeV C protein produces a variety of effects on STATs:
suppression of IFN-stimulated phosphorylation of STATs
(STAT1, STAT2, and STAT3) (Komatsu et al., 2000); im-
pairment of STAT1 dephosphorylation (Komatsu et al.,
2002); and induction of formation of a STAT1 high molec-
ular mass complex (HMMC) (Takeuchi et al., 2001). Of
these effects, it has been recently found that the inhibition of
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STAT2 tyrosine phosphorylation is crucial for the blockade
of IFN- signaling (Gotoh et al., 2003). In contrast to the
anti-IFN- mechanism, a molecular basis for the SeV anti-
IFN- mechanism has not been fully understood yet. This
study is designed to shed light on how the SeV C protein
inhibits IFN- signaling.
IFN- signaling is initiated with the binding of dimeric
IFN- to the IFN- receptor. The binding causes transphos-
phorylation and activation of the receptor associated ki-
nases, JAK1 and JAK2 (for review, see Stark et al., 1998).
The activated JAKs phosphorylate an IFN- receptor sub-
unit, IFNGR1, on Tyr440, which provides a docking site for
the SH2 domain of STAT1 (Greenlund et al., 1994, 1995;
Igarashi et al., 1994). Upon binding to the docking site,
STAT1 is phosphorylated on Tyr701 (Schindler et al., 1992;
Shuai et al., 1992, 1993). The tyrosine-phosphorylated
STAT1 (pY-STAT1) forms a homodimer termed -acti-
vated factor (GAF) through a reciprocal interaction between
the SH2 domain and the phosphorylated Tyr701, then trans-
locates into the nucleus, and binds to -activated sequence
(GAS) elements to activate IFN-stimulated genes (ISGs).
Two species of STAT1, STAT1 and STAT1, are present
in cells as a result of differential splicing but only STAT1
functions as a component of active GAF. Because STAT1
lacks the STAT1 C-terminal transactivation domain
(TAD) (38 amino acids) containing Ser727. Phosphorylation
of STAT1 on Ser727 is indeed essential for the maximal
activation of transcription by GAF (Wen et al., 1995). Tran-
scriptional activation function of GAF further requires the
interaction between STAT1 and cyclic-AMP response ele-
ment binding protein (CREB)-binding protein (CBP)/p300
(Zhang et al., 1996).
The SeV C protein is expressed as a nested set of four
proteins, C, C, Y1, and Y2, from overlapping open reading
frames in the P/V/C gene transcripts (Curran and Kolakof-
sky, 1989; Giorgi et al., 1983). Translation of the C, C, Y1,
and Y2 is initiated at 81ACG, 114AUG, 183AUG, and
201AUG, respectively, and terminated at the same position,
UAA728. Even the shorter forms Y1 and Y2 are capable of
inhibiting the IFN response (Garcin et al., 2000; Kato et al.,
2001). SeV not only inhibits IFN- stimulated phosphory-
lation of STATs (Komatsu et al., 2000) but also affects
IFN- stimulated phosphorylation of STAT1 (Komatsu et
al., 2002; Takeuchi et al., 2001). The effects, however, are
rather complicated. Tyrosine phosphorylation in response to
short-term IFN- stimulation is suppressed at the early
phase of infection, but the suppression is subsequently ab-
rogated (Takeuchi et al., 2001). Consistent with the abro-
gation, the inhibition of tyrosine phosphorylation is not
observed when a sufficient amount of the C protein is
constitutively expressed in HeLa cells in the absence of the
other viral proteins (Komatsu et al., 2002; Saito et al.,
2002). Interestingly, once the pY-STAT1 level is elevated
in either infected cells or the C-expressing cells, the high
level of pY-STAT1 is maintained for a long time. This is
explainable in part due to the suppressive effect of the C
protein on dephosphorylation of pY-STAT1 (Komatsu et
al., 2002). SeV infection also affects serine phosphorylation
kinetics of STAT1 but allows STAT1 to be doubly phos-
phorylated on Tyr701 and Ser727 (Komatsu et al., 2002). This
assures us that the C protein targets processes after the
STAT1 phosphorylation for the inhibition of the IFN-
response. The C protein physically associates with STAT1
in infected cells (Garcin et al., 2002; Takeuchi et al., 2001),
resulting in formation of a STAT1 HMMC (over 2 MDa)
(Takeuchi et al., 2001). This HMMC cannot be detected as
a single band by native polyacrylamide gel electrophoresis
(PAGE) analysis because it is too large to enter a native gel
(Takeuchi et al., 2001). Therefore, detection of no GAF
band in the extract containing the C protein by electro-
phoretic mobility shift assays (EMSAs) does not imply
the loss of the GAS binding ability of the C-associated
pY-STAT1, but rather indicates retention of pY-STAT1
molecules in a gel well (Takeuchi et al., 2001).
Under these circumstances, we attempted to determine
the binding capacity of pY-STAT1 associated with the C or
truncated C proteins, for GAS elements. The results dem-
onstrate that the C-terminal half-fragment (aa 85–204) of
the C protein, with both the STAT1 binding and the anti-
IFN- abilities comparable to the full-size C, inhibits bind-
ing of GAF to a GAS element. We thus propose a hypoth-
esis that the C proteins (C, Y1, and Y2) prevent GAF from
binding to GAS elements through their interaction with
STAT1.
Results
Feature of the C-STAT1 complex
The C protein inhibits the IFN- response by targeting
processes downstream of the STAT1 phosphorylation
(Komatsu et al., 2002; Takeuchi et al., 2001). This finding
prompted us to examine the binding capacity of the C-
associated pY-STAT1 for GAS elements or CBP/p300.
However we were confronted with a difficulty in this anal-
ysis because the native PAGE analysis could not detect the
C-associated STAT1 as a band (Takeuchi et al., 2001). The
C-associated STAT1 complex (over 2 MDa) is too large to
enter a native gel and consequently remains in a gel well.
This implies that the binding capacity of the C-associated
pY-STAT1 for GAS probe or CBP/p300 cannot be evalu-
ated by EMSAs, whose electrophoresis and gel conditions
are the same as those of the native PAGE.
To overcome this problem, we attempted to select a
shorter C fragment, which could bind to STAT1 but allow
STAT1 to enter a native gel, from the truncated C proteins
previously generated (Gotoh et al., 2003). The C (aa 1–204),
Y1 (aa 24–204), and Y2 (aa 30–204) are original products
translated from the P/C/V gene transcripts in infected cells
(Fig. 1). The D1 (aa 85–204) and D2 (aa 127–204) are
N-terminally truncated proteins of the C, while the D3 (aa
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30–126) is a C-terminally truncated protein of the Y1 (Fig.
1). These proteins are constitutively expressed as N-termi-
nal RGSH6 (RGS-His) epitope-tagged proteins in HeLa
cells by establishment of permanent cell lines (Gotoh et al.,
2003). The C, Y1, Y2, and D1 that contain a C-terminal half
of the C protein not only bind to STAT1 (Fig. 1) but also
inhibit IFN- signaling (Gotoh et al., 2003). Native PAGE
analysis of these cell lines revealed no conspicuous STAT1
band in the C-, Y1-, or Y2-expressing cells (Fig. 2A, lanes
2–4). In contrast, sodium dodecyl sulfate (SDS)–PAGE
analysis showed expression of nearly equal amounts of
STAT1 among the cell lines (Fig. 2B). These results sug-
gested that the Y1 and Y2 had the STAT1-HMMC-inducing
capacity similar to that of the C. On the other hand, a
supershifted STAT1 band was seen in the D1-expressing
cells (Fig. 2A, lane 5). Unfortunately, we failed to detect
each of the truncated C proteins, including the D1 on this
membrane, due to a high background in the immunodetec-
tion with the anti-RGS-His antibody. An anti-C antibody
also did not work well to detect truncated-C specific bands,
because the D1, D2, and D3 were hardly recognized by the
anti-C antibody (data not shown), and the C, Y1, and Y2
associating with STAT1 probably remain at gel wells due to
their STAT1-HMMC formation capacity. To obtain the data
supporting that the supershift of the STAT1 band result
from association with the D1, the following alternative
experiments were conducted. First, a pull-down assay of the
extracts was performed with Ni-nitrilotriacetic acid (NTA)
beads that specifically bind to His epitope-tagged proteins.
STAT1 was pulled down specifically from the C-, Y1-, Y2-,
and D1-expressing cell extracts (Fig. 2C, lanes 2–5), indi-
cating association of STAT1 with the C, Y1, Y2, or D1 in
the extracts. Second, HeLa cell extracts were mixed in vitro
with RGS-His epitope-tagged D1 (His-D1) or dihydrofolate
reductase (DHFR) (His-DHFR) purified from Escherichia
coli (E. coli) and then subjected to native PAGE analysis
(Fig. 2D). This analysis showed that purified D1 shifted the
STAT1 band to the position similar to that seen in the
D1-expressing cell extract (Fig. 2D, lane 2; Fig. 2A, lane 5).
These data indirectly support the idea that the supershifted
band represents a STAT1–D1 complex. This property of the
STAT1-D1 complex led us to a bright prospect for exami-
nation of the binding capacity of the D1-associated STAT1
to a GAS probe by EMSAs. It is unclear at present why the
STAT1-D1 complex migrated significantly faster than the
C-, Y1-, or Y2-STAT1 complex. One possible explanation
is that the C, Y1, and Y2 form homocomplexes but the D1
is monomeric. Unfortunately, a pull-down assay with glu-
tathione-sepharose beads and mixtures consisting of various
combinations of purified His-C fragments (His-C, His-Y1,
His-Y2, and His-D1) and glutathione-S-transferase (GST)
fusion C fragments (GST-C, GST-Y1, GST-Y2, and GST-
D1) could not provide positive evidence for this hypothesis
(data not shown). This issue was not further investigated in
this study.
The D1 inhibits the IFN- response as effectively as the
full-size C
We next checked the effect of the truncated C proteins
including the D1 on the IFN- response. The cells were
Fig. 2. Native PAGE analysis of truncated-C-mediated STAT1 complexes.
(A and B) Extracts from the HeLa cell lines constitutively expressing each
of RGS-His epitope-tagged truncated-C proteins were subjected to native
PAGE (Native) (A) or SDS–7.5% PAGE (B) for Western blot analyses
with anti-STAT1 antibody. (C) Proteins associating with RGS-His epitope-
tagged proteins in each of the cell extracts were precipitated with Ni-NTA
beads. Bound proteins were separated by SDS–7.5% PAGE for Western
blot analyses with anti-STAT1 antibody. (D) HeLa cell extracts (8 g)
were mock-mixed () or mixed with 0.5 g of purified His-D1 (D1) or
His-DHFR (DHFR) and incubated for 30 min. Proteins in the mixtures
were separated by native PAGE for Western blot analyses with anti-
STAT1 antibody. Arrows indicate supershifted STAT1 bands, which prob-
ably represent the D1-STAT1 complex.
Fig. 1. A schematic diagram of the C protein and its truncated proteins. The
C (aa 1–204), Y1 (aa 24–204), and Y2 (aa 30–204) are original products
translated from the P/C/V gene transcripts in infected cells. The D1 (aa
85–204) and D2 (aa 127–104) are N-terminally truncated-C fragments,
while the D3 (aa 30–126) is a C-terminally truncated Y2 fragment. Their
STAT1-binding capacities are also indicated.
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transfected with the IFN--responsive luciferase reporter
plasmid, and the induction of luciferase was assayed after
treatment with IFN- (Fig. 3A). Fig. 3A clearly demon-
strated that the C, Y1, Y2, and D1 inhibited the IFN-
response, while the D2 and D3 did not. Similar results were
obtained from the transient expression experiments, in
which each of the truncated C proteins without RGS-His
epitope tag was transiently expressed by transfection with
RGS-His epitope tag minus truncated-C plasmids previ-
ously created (Gotoh et al., 2003 and data not shown). The
expression levels of the truncated-C proteins in the estab-
lished cell lines were distinct from one another, as shown in
Fig. 3B. The level of the Y1 was the highest, whereas the
levels of the C, Y2, D1, and D3 were 0.37-, 0.76-, 0.58-, and
0.60-fold as high as that of the Y1. Since the expression
level of the D3 is comparable to that of the D1, the inability
of the D3 to inhibit the IFN- response was attributable to
its intrinsic property. However, the possibility could not be
excluded that the lack of the inhibitory effect of the D2 is
due to its low expression level, since the D2 was too small
in amount and could be detected only after long exposure
(Gotoh et al., 2003 and data not shown). To confirm the
effect of the truncated-C proteins on IFN--stimulated tran-
scription, levels of IRF-1 as an ISG product before and after
IFN- treatment were also examined by Western blot anal-
ysis. As shown in Fig. 3C, induction of IRF-1 was sup-
pressed in the C-, Y1-, Y2-, and D1-expressing cells (Fig.
3C, lanes 3–10). The suppression of IRF-1 induction by the
C, Y1, Y2, and D1 was incomplete, but the incompleteness
was also observed in SeV-infected cells (Fig. 3D). It is
unclear at present whether this incompleteness represents
inability of the C protein to inhibit an alternative STAT1-
independent IFN- pathway (Ramana et al., 2002) or a
simple signaling leak on the STAT1-dependent pathway.
Nevertheless, these results demonstrated that the C-terminal
half of the C protein, the D1, was sufficient for exerting the
anti-IFN- effect of the full-size C or SeV infection.
Effect of the truncated-C proteins on IFN- stimulated
phosphorylation of STAT1
The C and the truncated-C proteins with the STAT1-
binding ability suppress IFN- stimulated phosphorylation
of STAT1 to various degrees (Gotoh et al., 2003). This
naturally demanded examination of their effects on IFN--
stimulated phosphorylation of STAT1. Treatment of HeLa
cells with IFN- resulted in rapid tyrosine phosphorylation
of STAT1 (Fig. 4A, mock, lanes 2–4). The elevated pY-
STAT1 level decreased from 4 h posttreatment (pt) and
returned nearly to the basal level by 24 h pt. The decrease
in the pY-STAT1 level is explained by dephosphorylation
of pY-STAT1 by a nuclear phosphatase (Haspel and Dar-
nell, 1999; Haspel et al., 1996). In SeV-infected cells, ty-
rosine phosphorylation pattern was strikingly changed (Fig.
4A, SeV). When infected cells were treated with IFN- at
2 h postinfection (pi), the immediate elevation of the pY-
Fig. 3. The C-terminal half fragment of the C (D1) inhibits the IFN-
response. (A) Subconfluent monolayers of the cell lines were doubly
transfected with pGAS-TA-luc and pRL-TK-luc plasmids. At 20 h
posttransfection, the culture media were mock-replaced (open bar) or
replaced (closed bar) with those containing IFN- (500 IU/ml). At 6 h
after the replacement, the cells were lysed and measured for luciferase
activities. Firefly luciferase activity, expressed in relative light units,
was normalized to renilla luciferase activity. The data represent the
mean values of the normalized luciferase activities from triplicate
samples. (B) Extracts from the established cell lines were subjected to
SDS–13% PAGE, followed by Western blot analyses with anti-RGS-
His antibody. Arrowheads indicate positions of the C, Y1, Y2, D1, and
D3. Relative densities of the truncated-C fragment bands were deter-
mined by using FluorChem IS8800 (Alpha Innotech Corp.). (C and D)
HeLa cells were infected with SeV (a multiplicity of infection (m.o.i.)
of 10) 4 h before IFN- treatment. The SeV-infected cells (SeV), as
well as uninfected HeLa cells (HeLa) and the established cell lines,
were mock-treated () or treated () with IFN- (500 U/ml) for 16 h.
Proteins in the cell extracts were separated by SDS– 6.5% PAGE for
Western blot analyses with anti-IRF-1 antibody.
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STAT1 level (Fig. 4A, mock, lanes 2–4) was remarkably
suppressed (Fig. 4A, SeV, lanes 2–4). Instead the pY-
STAT1 level inversely increased from 4 h pt (Fig. 4A, SeV,
lanes 5–7). The suppressive effect on the immediate phos-
phorylation was not seen, when infected cells were treated
with IFN- at the middle phase of infection (Takeuchi et al.,
2001). Consistent with this observation, IFN--stimulated
tyrosine phosphorylation was not inhibited in a HeLa cell
line constitutively expressing a sufficient amount of the C
protein (Komatsu et al., 2002). The abrogation of the inhib-
itory effect at the middle phase of infection partly explained
the paradoxical increase in the pY-STAT1 level from 4 h pi
(Fig. 4A, SeV, lanes 5–7). One should be reminded that the
dephosphorylation process of pY-STAT1 is also impaired in
infected cells, as well as the C-expressing cells (Komatsu et
al., 2002). Since the pY-STAT1 level is determined by the
balance of tyrosine phosphorylation and dephosphorylation
turnovers, this impairment necessarily contributes to the
prolongation of the high pY-STAT1 level in infected cells
(Fig. 4A, SeV, lanes 5–7) or the C-expressing cells (Kom-
atsu et al., 2002). These complicated effects of SeV infec-
tion and the C protein urged us to examine the effect on
STAT1 phosphorylation under the two conditions; short-
term and long-term IFN- stimulation.
First, levels of pY-STAT1, STAT1 phosphorylated on
Ser727 (pS-STAT1), and STAT1 in the cell lines after short-
term (1 h) IFN- treatment were examined by Western blot
analysis (Fig. 4Babc). Consistent with the previous results
(Komatsu et al., 2002), the C did not inhibit tyrosine phos-
phorylation of STAT1 (Fig. 4Ba, lanes 1–4). In contrast,
the Y1, Y2, and D1 suppressed tyrosine phosphorylation
(Fig. 4Ba, lanes 5–10). On the other hand, IFN--stimulated
serine phosphorylation was inhibited in all the truncated-C
proteins with the STAT1 binding ability (the C, Y1, Y2, and
D1) (Fig. 4Bb, lanes 3–10). The D2 and D3 with no STAT1-
binding ability did not inhibit phosphorylation on both
Fig. 4. The C and the truncated-C proteins with the STAT1 binding ability do not inhibit completely IFN--stimulated phosphorylation of STAT1. (A) HeLa
cells were mock-infected or infected with SeV at an m.o.i. of 10. At 2 h pi, the culture media was replaced with fresh media containing IFN- (500 U/ml).
The cells were harvested at indicated time points after the medium replacement. (B) Confluent monolayers of the cell lines were treated with IFN- (500 U/ml)
for 0 (a, b, c, d, e, f), 1 (a, b, c), or 16 (d, e, f) h. Proteins in the cell extracts were separated by SDS–6.5% PAGE for Western blot analyses with
anti-pY-STAT1 antibody (A, Ba, Bd), anti-pS-STAT1 antibody (Bb, Be), and anti-STAT1 antibody (A, Bc, Bf). It should be noted that tyrosine-
phosphorylated STAT1 molecules (pY-STAT1 and pYpS-STAT1) migrate slower than tyrosine-unphosphorylated STAT1 molecules (STAT1 and pY()pS-
STAT1 (STAT1 phosphorylated only on Ser727)) do. Arrowheads indicate positions of the tyrosine-phosphorylated STAT1.
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Tyr701 and Ser727 (Fig. 4Bab, lanes 1, 2, and 11–14). These
results suggested that the suppressive effects were related to
the STAT1-binding property.
As described above, the elevated pY-STAT1 level in
HeLa cells decreases from 4 h pt and returns nearly to the
basal level by 24 h pt (Fig. 4A, mock, lanes 5–7). Indeed,
the pY-STAT1 bands in the D2- or D3-expressing cells, as
well as the control HeLa cells, became faint at 16 h after
addition of IFN- (Fig. 4Bd, lanes 2, 12, and 14). On the
contrary, the long-term IFN- stimulation caused marked
elevation of the pY-STAT1 levels in the C-, Y1-, Y2-, and
D1-expressing cells (Fig. 4Bd, lanes 3–10), as seen in SeV-
infected cells (Fig. 4A, SeV). Since small amounts of pY-
STAT1 were generated by short-term IFN- stimulation
even in the Y1-, Y2-, and D1-expressing cells (Fig. 4Ba,
lanes 6, 8, and 10), this elevation may result from accumu-
lation of pY-STAT1 due to possible inhibitory effects of the
C, Y1, Y2, and D1 on the pY-STAT1 dephosphorylation
process. The pY-STAT1 generated in these cell lines was
also phosphorylated on Ser727 (Fig. 4Be, lanes 4, 6, 8, and
10). In conclusion, the C and all the truncated-C proteins
with the anti-IFN- ability allowed STAT1 to be doubly
phosphorylated on Tyr701 and Ser727 by short-term or long-
term IFN- stimulation. These results supported the previ-
ous conclusion that the target of the C protein for the
inhibition of the IFN- response is present in processes after
STAT1 phosphorylation.
The aberrant pY-STAT1 complex generated in the
presence of the D1 does not appear to bind to the GAS
DNA probe
The extracts used in Fig. 4Babc were subjected to native
PAGE for Western blot analyses with anti-pY-STAT1 an-
tibody (Fig. 5A) and to EMSAs with 32P-labeled GAS probe
(Fig. 5B). Since the C, Y1, Y2, and D1 cause STAT1
retention at gel wells or a supershift of STAT1 band (Fig.
2A, lanes 2–5), the density of both the pY-STAT1 dimer
and the GAF bands is expected to decrease in these cell
lines. Indeed both bands became faint in the C-, Y2-, and
D1-expressing cells (Fig. 5AB, lanes 2, 4, and 5) or disap-
peared in the Y1-expressing cells (Figs. 5A and B, lane 3).
A pull-down assay of the extracts with Ni-NTA beads
demonstrated association of the C, Y1, Y2, and D1 with
pY-STAT1 (Fig. 5D, lanes 2–5). The levels of the associ-
ated pY-STAT1 (Fig. 5D, lanes 2–5) corresponded to those
of pY-STAT1 present in the extracts (Fig. 5C, lanes 2–5).
Importantly, the densities of the faint STAT1 dimer and
GAS bands observed in the C-, Y2-, and D1-expressing
cells (Figs. 5A and B, lanes 2, 4, and 5) were in inverse
correlation with the expression levels of the C, Y2, and D1
proteins (Fig. 3B). This suggested that these faint bands
represented populations of pY-STAT1 molecules, which
did not associate with each of the truncated C proteins.
Remarkably, native PAGE analysis revealed another faint
band, which showed an aberrant pY-STAT1 complex, close
to the top in the D1-expressing cells (Fig. 5A, lane 5, an
arrow). However, EMSAs did not show any apparent band
at the corresponding position (Fig. 5B, lane 5). This sug-
gested that the aberrant pY-STAT1 complex did not bind to
the GAS DNA probe.
The purified D1 inhibits binding of the pY-STAT1
homodimer to the GAS probe in vitro
To test the hypothesis that the D1 could deprive pY-
STAT1 homodimers of the GAS-binding ability by induc-
ing the aberrant pY-STAT1 complex formation, in vitro
assays were performed using the purified D1. The D1 was
purified from E. coli as GST fusion protein (GST-D1) or
RGS-His epitope-tagged D1 (His-D1). Extracts from the
IFN--treated HeLa cells (containing the pY-STAT1 dimer)
were mixed with GST-D1, GST, His-D1, or His-DHFR and
incubated for 30 min. The mixtures were then subjected to
native-PAGE (Figs. 6A and C) or EMSAs (Figs. 6B and D).
One microgram of GST-D1 shifted the pY-STAT1 band
(Fig. 6A, lane 2), whereas the same amount of GST did not
(Fig. 6A, lane 7). A decrease in the amount of GST-D1
resulted in a supershift of the shifted pY-STAT1 band (Fig.
6A, lanes 3–6). On the contrary, an EMSA revealed no
binding of these supershifted bands to 32P-labeled GAS
probe (Fig. 6B, lanes 2–6). His-D1 also caused a supershift
of the pY-STAT1 band (Fig. 6C, lanes 2–7), whereas His-
DHFR did not (Fig. 6C, lane 8). The positions of the pY-
STAT1 bands shifted by addition of 24 or 25 g of
His-D1 appeared to be same as that of the aberrant pY-
Fig. 5. Native PAGE analysis and EMSA of the established cell lines
stimulated with IFN-. (A and C) Confluent monolayers of the cell lines
were treated with IFN- (500 IU/ml) for 1 h. Extracts from the cells were
mixed with cold GAS probe and then subjected to native PAGE (Native)
(A) or SDS–6.5% PAGE (C) followed by Western blot analysis with
anti-pY-STAT1 antibody. (B) The extracts were subjected to EMSAs with
32P-labeled GAS probe. (D) The extracts were subjected to pull-down
assays with Ni-NTA beads. Bound proteins were separated by SDS–7.5%
PAGE for Western blot analysis with anti-pY-STAT1. An arrow indicates
a supershifted pY-STAT1 band.
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STAT1 complex generated in the D1-expressing cells (Fig.
6C, lanes 6 and 7; Fig. 5A, lane 5, an arrow). An EMSA
revealed no band (Fig. 6D, lanes 4–7) or only very faint
bands (Fig. 6D, lanes 2 and 3) at these positions. These
results demonstrated the ability of the purified D1 to inhibit
the binding of the pY-STAT1 dimers to the GAS probe.
The D1 binds to the N-terminal domain of STAT1
To understand how the D1 inhibits the GAF-GAS bind-
ing we attempted to determine the STAT1 domain respon-
sible for interacting with the D1. Functional domains of
STAT1 and STAT1 are shown in Fig. 7A. STAT1,
N-terminally truncated STAT1, and C-terminally truncated
STAT1 fragments (Fig. 7A) were synthesized in the pres-
ence of [35S]methionine by the in vitro transcription and
translation system (Fig. 7B). The [35S]methionine-labeled
STAT1 fragments were mixed with GST-D1 or GST and
subjected to pull-down assays with glutathione-sepharose
beads. All the STAT1 fragments that lost the N-terminal
domain (NTD) did not bind to GST-D1 (Fig. 7C, lanes
3–10), indicating that the D1 interacted with none of the
DNA binding domain, the SH2 domain, and the domain
containing Tyr701. On the other hand, all the C-terminally
truncated STAT1 fragments, including the NTD fragment,
could bind to GST-D1 (Fig. 7C, lanes 11–16). The binding
was specific, because GST did not bind to [35S]methionine-
labeled STAT1 fragments (Fig. 7C, lanes 2, 12, 14, and 16).
These results demonstrated that the D1 associated with
STAT1 through its interaction with the NTD.
Discussion
The present study proposes a hypothesis that the C pro-
tein prevents GAF from binding to GAS elements by bind-
ing to STAT1. The in vitro binding assays demonstrate that
the STAT1 domain responsible for interacting with the D1
is the NTD but not the SH2 domain nor the region contain-
ing Tyr701 (Fig. 7). Not only the extract containing the C,
Y1, and Y2 but also the purified D1 can convert the pY-
STAT1 homodimer, which has been already formed in the
extract, to the high molecular pY-STAT1 complex in vitro
(Figs. 6A and C) (Takeuchi et al., 2001). Furthermore, the
pY-STAT1 generated by IFN- stimulation efficiently
translocates into the nucleus in SeV-infected cells (Komatsu
et al., 2002). Since nuclear transport of pY-STAT1 requires
dimerization of pY-STAT1 rather than tyrosine phosphor-
ylation itself (Mowen and David, 1998), all these findings
support the idea that the C protein does not interfere with
dimerization of pY-STAT1 through the reciprocal interac-
tion between the SH2 domain and the phosphorylated
Tyr701 (Shuai et al., 1994). From this, it follows that the
crucial target of the C protein for the inhibition of the IFN-
response is likely present in processes after pY-STAT1
homodimerization. We here examined the effect of the D1
instead of the full-size C on the binding capacity of the
pY-STAT1 for the GAS site and demonstrated the inhibi-
tory activity of the D1 for the GAF-GAS binding. The D1
retains both the STAT1-binding and the anti-IFN- abili-
ties, comparable to those of the full-size C (Fig. 3) (Gotoh
et al., 2003). This full anti-IFN- capacity of the D1 is also
supported by the previous finding that even a shorter N-
terminally truncated fragment (aa 99–204) exhibits the anti-
IFN activity (Kato et al., 2002). As a natural consequence of
these findings, it is likely that the full-size C has the ability
to prevent GAF from binding to GAS elements. It is unclear
at present how the D1 inhibits the binding of the pY-STAT1
complex to the GAS probe. It is unlikely that the D1 and
GAS probe competitively bind to STAT1, because the D1
interacts with the NTD far from the DNA binding domain of
STAT1 (Fig. 7). Interestingly, the purified His-D1 pre-
vented GAF from binding to the GAS probe, even if added
to the extract after addition of the GAS probe (Gotoh et al.,
Fig. 6. In vitro inhibition of the GAF-GAS binding by purified GST-D1 (A,
B) or His-D1 (C, D). HeLa cells were treated with IFN- (500 IU/ml) for
1 h. Extracts from the cells were mock-mixed () or mixed with indicated
amounts of purified GST-D1, GST, His-D1, or His-DHFR and then incu-
bated for 30 min. The mixtures were subjected to native PAGE (Native) for
Western blot analyses with pY-STAT1 antibody (A, C) or to EMSAs with
32P-labeled GAS probe (B, D). Arrows indicate positions of the pY-STAT1
bands supershifted by addition of GST-D1 (A) or His-D1 (C).
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unpublished result). Accordingly, the D1 may induce con-
formational change of the GAF DNA binding domain
through its interaction with the NTD.
The STAT1 NTD is an important region for the dephos-
phorylation process of pY-STAT1 (Shuai et al., 1996), as
well as the STAT1-CBP/p300 interaction (Zhang et al.,
1996), and the stabilization of a pair of STAT1 homodimers
to cooperate in binding to tandem GAS sites (Vinkemeier et
al., 1996; Xu et al., 1996). Accordingly, the interaction of
the C protein with the STAT1 NTD may be related to the
impairment of STAT1 dephosphorylation observed in in-
fected cells or the C-expressing cells (Komatsu et al., 2002).
The CBP/p300 interacts with two regions, the NTD and the
transactivation domain (TAD), of STAT1 (Fig. 7A) and
plays a crucial role in the transcriptional function of GAF
(Zhang et al., 1996). One can naturally hypothesize that the
C protein may inhibit the IFN- response by preventing
CBP/p300 from participating in the transcriptional process
of GAF. We tried to examine effect of the C or the D1 on
the STAT1-CBP/p300 interaction, but failed in detecting
the STAT1-CBP/p300 interaction itself in HeLa cell ex-
tracts. Even in vitro binding assays with a GST fusion CBP
fragment and a GST fusion p300 fragment (GSTCBP571-
687 and GSTp300/566-664) (a gift from Dr. R. Goodman),
which were reported to bind to STAT1 (Zhang et al., 1996),
could not provide positive evidence for the STAT1-CBP/
p300 interaction.
The C, Y1, Y2, and D1 with the STAT1-binding ability
transiently inhibited serine phosphorylation of STAT1 (Fig.
4Bb). Inhibition of the tyrosine phosphorylation was also
seen with the exception of the C (Fig. 4Ba). On the contrary,
the D2 and D3 with no STAT1-binding capacity never
exhibited the inhibitory effects on both tyrosine and serine
phosphorylation of STAT1. These results suggest that the C
protein affects the STAT1 phosphorylation event through its
interaction with STAT1. In infected cells, IFN--stimulated
tyrosine phosphorylation of STAT1 was suppressed at the
early phase, but this suppression was subsequently abro-
gated (Takeuchi et al., 2001). Since the constitutively ex-
pressed C does not suppress IFN--stimulated tyrosine
Fig. 7. The C-terminal half domain of the C protein interacts with the N-terminal domain of STAT1. (A) A schematic diagram of STAT1, STAT1, and
constructs of truncated STAT1 fragments. NTD, N-terminal domain; CCD, coiled coil domain; DBD, DNA binding domain; LD, linker domain; SH2, Src
homology domain 2; TAD, transactivation domain. The numbered tyrosine (Y) and serine (S) residues show the positions of phosphorylation. (B and C) The
STAT1 fragments were synthesized in the presence of [35S]methionine by the in vitro transcription and translation system and then separated by SDS–11%
PAGE (B). The [35S]methionine-labeled translation products were mixed with GST-D1 (D1) or GST (G) and then incubated for 1 h. After extensive wash
with the binding buffer, bound proteins were eluted in SDS sample buffer and then separated by SDS–11% PAGE. The gels were treated with Amplify, dried,
and exposed to X-ray films for about 1 day (B) or 1 month (C).
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phosphorylation of STAT1 (Fig. 4Ba, lane 4), we specu-
lated that the major population of the four C proteins (C, C,
Y1, and Y2) expressed in infected cells might shift from the
Y1 and Y2 to the C during the progress of infection. We,
however, found that the C was expressed constantly as the
major species during the whole course of infection (Gotoh
et al., unpublished result). It is therefore still unclear how
SeV inhibits IFN--stimulated tyrosine phosphorylation in
the early phase of infection.
Garcin et al. have recently reported that two types of
interaction between the C protein and STAT1 (Garcin et al.,
2003). They showed that unphosphorylated STAT1 inter-
acted with both the C and the C10–15 (C mutant with
deletion of amino acids 10 to 15, which are present only in
C and C), whereas pY-STAT1 specifically interacted with
the C but not C10–15. The latter-type interaction, how-
ever, was not observed in our SeV-HeLa system. All the Y1,
Y2, and D1, which lost the region containing amino acids
10 to 15, interacted with pY-STAT1 (Fig 5, lanes 2–5).
Pull-down assays with GST-C, GST-Y1, GST-Y2, and
GST-D1 further showed equal binding abilities of the
four GST proteins for both STAT1 and pY-STAT1 (Gotoh
et al., unpublished result). The interaction of pY-STAT1
with the C, Y1, Y2, and D1 was observed even if
pY-STAT1 is generated by IFN- stimulation, as previ-
ously described (Gotoh et al., 2003). It is unclear how the
discrepancy took place. Since the other domains, except for
the NTD STAT1, is not required for interacting with the D1,
it is of interest to understand how that C10–15 contain-
ing the Y1, Y2, D1 region loses the binding ability for
pY-STAT1.
There appears to be a small population of pY-STAT1
molecules, which does not associate with the C and which
can bind to the GAS probe, in the C-expressing cells (Figs.
5A and B, lane 2). Nevertheless, the inhibition of the IFN-
response in the C-expressing cells is comparable to that in
the Y1 and Y2-expressing cells (Fig. 3). The possibility
therefore cannot be ruled out completely that there is an-
other mechanism besides the inhibition of the GAF-GAS
binding. This possible mechanism is now under investiga-
tion.
Materials and methods
Cells and a virus
HeLa cells were maintained in Dulbecco’s minimum
essential medium (DMEM) supplemented with 10% fetal
calf serum. HeLa cell lines expressing the N-terminally
RGS-His epitope-tagged C (aa 1–204), Y1 (aa 24–204), Y2
(aa 30–204), D1 (aa 85–204), D2 (aa 127–204), or D3 (aa
30–126) were maintained in DMEM supplemented with
10% fetal calf serum and 0.8 mg/ml geneticin (G418)
(Gotoh et al., 2003). SeV (strain SeVpB) is propagated in
the allantoic cavity of 10-day-old embryonated eggs as
previously described (Yokoo et al., 1999).
Plasmid constructs
To create a pQE32-D1 plasmid expressing His-D1 in E.
coli, the D1 DNA fragment purified from pTRE2-D1
(Gotoh et al., 2003) doubly digested with BamHI and Hin-
dIII was cloned into the corresponding site of pQE-32
(Qiagen). To generate plasmids expressing full-size STAT1
or truncated forms of STAT1 under the control of the T7
promoter, full-length and truncated STAT1 DNA fragments
were amplified by PCR, using pEFBOS-HA-STAT1 (Naka-
jima et al., 1996) (a gift from Dr. T. Hirano) as a template.
Forward primers, F1 (5-AAGCTTBamHIggatccAG1A-
TGTCTCAGTGGTACGAA-3) , F1 3 7 (5-AAGC-
TTBamHIggatccAG409GACAAACAGAAAGAGCTT-3), F318
(5-AAGCTTBamHggatccAG952GTGGTGGAAAGACAG-
CCC-3), F488 (5-AAGCTTBamHggatccAG1465AC-
TCCACCATGTGCACGA-3), and F577 (5-AAG-
CTTBamHggatccAG1729TGCATCATGGGCTTCATC-3), and
a reverse primer R750 (5-AAGCTTNotIgcggccgcTTA2253CTA-
TACTGTGTTCATCAT-3) were used for generating full-
length STAT1 and N-terminally truncated forms of STAT1.
Italics indicate nucleotide sequences that are not involved in a
STAT1 open reading frame. Restriction enzyme recognition
sites are in lowercase. Forward primer, F1, and reverse primers,
R712 (5-AAGCTTNotIgcggccgcTTA2136AACTTCAGA-
CACAGAAAT-3), R487 (5-AAGCTTNotIgcggccg-
cTTA1464CAGGAAGAAGGACAGATT-3), and R136 (5-
AAGCTTNotIgcggccgcTTA408TAACATCACTGTGCTCTG-3),
were used for generating C-terminally truncated fragments of
STAT1. The PCR-amplified DNA fragment was doubly di-
gested with BamHI and NotI and then inserted into the corre-
sponding position of pcDNA3.1 vector (Invitrogen). Finally
RGS-His epitope tag was appended to the N-terminus of the
STAT1 fragments by insertion of annealed oligonucleotides
(5-TATGAGAGGATCGCATCACCATCACCAT-
CACGG-3 and 5-GATCCCGTGATGGTGATGGTGAT-
GCGATCCTCTCATAGTAC-3) into the KpnI and BamHI
sites in the pcDNA3.1-STAT1 fragment plasmids created
above.
Purification of GST-D1 and His-D1 proteins from E. coli
GST, GST-D1, His-D1, and His-DHFR proteins were
expressed in E. coli (BL21) transformed with pGEX-5X-1
(Amersham Pharmacia Biotech), pGEX-D1 (Gotoh et al.,
2003), pQE32-D1, and pQE-40 (Qiagen), respectively, by
adding isopropyl--thiogalactopyranoside (final concentra-
tion of 1 mM). GST and GST-D1 were purified with glu-
tathione-sepharose beads as described previously (Gotoh et
al., 2003), while His-D1 and His-DHFR were purified with
Ni-NTA agarose beads (Qiagen) according to manufacturer
protocol. The final eluate was dialyzed overnight in 50 mM
Tris–HCl pH 7.5, 5 mM MgCl2, 100 mM NaCl, 10% glyc-
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erol, 5 mM 2-mercaptoethanol and stored at 80°C until
use.
Preparation of a mammalian cell extract
Cells were lysed in an extraction buffer (10 mM HEPES,
pH 7.9, 300 mM NaCl, 0.25% NP-40, 10% glycerol, 1 mM
EDTA, 1 mM EGTA, 1 mM Na3VO4, 1 mM DTT) con-
taining a protease inhibitor cocktail (Sigma) as described
previously (Takeuchi et al., 2001). After centrifugation, the
clarified supernatant was stored at 80°C.
Native PAGE
Extracts (5–10 g) were diluted three to five times with
the EMSA buffer (10 mM Tris–HCl pH 7.6, 1 mM EDTA,
1 mM DTT, and 5% glycerol) containing 1 ng/l of cold
GAS oligonucleotides and then separated by 5% PAGE in
0.5  TBE buffer as described previously (Takeuchi et al.,
2001).
Western blot analysis
A Western blot analysis was performed, as described
previously (Takeuchi et al., 2001), with anti-pY-STAT1
(no. 9171; Cell Signaling Technology, Beverly, MA), anti-
pS-STAT1 (no. 06-802; Upstate Biotechnology, New
York), anti-STAT1 (sc-346), anti-IRF-1 (sc497) (Santa
Cruz Biotechnology, Santa Cruz, CA), and anti-RGS-His
(no. 34610; Qiagen) antibody.
Pull-down assay with Ni-NTA beads
Cells were lysed in a lysis buffer (50 mM NaH2PO4, 300
mM NaCl, 0.25% NP-40, 5 mM 2-mercaptoethanol) con-
taining the protease inhibitor cocktail. After centrifugation,
the clarified lysates (300 g) were incubated with Ni-
NTA beads at 4°C for 2 h. The beads were then washed four
times with the lysis buffer containing 20 mM imidazole.
Bound proteins were eluted by adding the lysis buffer con-
taining 250 mM imidazole or a SDS–gel loading buffer and
separated by SDS–7.5% PAGE for Western blot analyses.
Reporter gene assay
Cells in a 24-well plate were transfected with pGAS-TA-
Luc (0.5 g) (Clontech) together with pRL-TK-luc (0.03
g) (Clontech) by using Polyfect transfection reagent (Qia-
gen). At 20 h posttransfection, the medium was replaced
with a fresh medium or a medium containing human recom-
binant IFN- (500 IU/ml) (R&D Systems Inc., Minneapolis,
MN) and incubated further for 6 h. Luciferase activities in
the cell lysates were measured by the Dual-luciferase re-
porter assay system (Promega) according to manufacturer
protocol. Relative activity was expressed by a ratio of firefly
luciferase activity to renilla luciferase activity.
EMSA
EMSAs were performed with a 32P-labeled GAS probe
under the same conditions as previously described (Takeu-
chi et al., 2001). To generate a 32P-labeled GAS probe, the
5 terminus of the annealed synthetic DNAs (5-GATC-
GGGAAAGGGAAACCGAAACTGAAGCC-3 and 5-
GATCGGCTTCAGTTTCGGTTTCCCTTTCCC-3) de-
rived from a GAS site of the human IRF-1 gene (Leonard
and Sen, 1996) was labeled with [-32P]ATP (222 TBq/
mmol; Amersham Pharmacia Biotech) by using T4 bacte-
riophage polynucleotide kinase.
In vitro translation of STAT1 fragments
To prepare [35S]methionine-labeled STAT1 fragments,
in vitro transcription and translation was performed by the
TNT quick coupled transcription/translation systems (Pro-
mega) with Redivue L-[35S]methionine (37 TBq/mmol)
(Amersham Pharmacia Biotech) and the pcDNA3.1-STAT1
fragment plasmids.
Determination of STAT1 domain interacting with the D1
Purified GST-D1 or GST (2–4 g) was mixed with 10 l
of 50% slurry of glutathione-sepharose beads and incubated
for 1 h with gentle rotation. After centrifugation, the beads
were further incubated with each of in vitro translated
[35S]methionine-labeled STAT1 fragments at 4°C for 1 h.
The beads were then washed four times with the extraction
buffer. Bound proteins were eluted by adding a SDS–gel
loading buffer and separated by SDS–11% PAGE. After
treatment with Amplify (Amersham Pharmacia Biotech),
the gels were dried and exposed to X-ray films.
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